DentistryIQ reports, “A new early-stage oral cancer detection test for dental professionals could offer ‘unprecedented level of actionable insight into their patients’ health,’” according to Viome Life Sciences, the company launching it. The Oral Health Pro with CancerDetect is “a device that, according to a company press release , uses proprietary RNA sequencing technology to measure gene expression of the oral microbiome and human cells in each patient’s saliva to identify early biomarkers associated with oral and throat cancer.”
Becker’s Dental Review reports, “In addition to detecting oral and throat cancer, the test also detects biomarkers associated with other oral health conditions, including poor gum health, cavities and fungal activity.”
According to Dental Products Report, “The test has received an FDA Breakthrough Device Designation for accelerated review.”